Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page. The displayed site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:45:10.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0. The page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:15:14.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and a Home link, replacing the previously visible study details and related content. The study record information is no longer accessible on the page.
    Difference
    18%
    Check dated 2026-09-23T01:06:21.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays revision v3.7.0, replacing the previous v3.6.6. This indicates the study page has been updated to a newer version.
    Difference
    0.1%
    Check dated 2026-09-16T00:16:10.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a small backend/template update for the study page. This update does not alter the study details, eligibility criteria, or locations; it seems to be a platform version bump.
    Difference
    0.1%
    Check dated 2026-09-01T19:43:10.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    This change updates the page's underlying version from v3.6.4 to v3.6.5, indicating a small maintenance update to the template or platform without modifying the study details.
    Difference
    0.1%
    Check dated 2026-08-11T17:59:09.000Z thumbnail image

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.